快而精医药(QGEN)

50.35 -0.11 -0.218%

今开:49.98昨收:50.46
最高:50.5 最低:49.73
涨停价:0.0跌停价:0.0
总市值:1.1464695E10

快而精医药的热门评论

快而精医药(QGEN)2020-03-04 06:30

$快而精医药(QGEN)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-20-028699 Act: 34 Size: 180 KB 网页链接查看全文

快而精医药(QGEN)2019-10-08 18:20

$快而精医药(QGEN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-10-08 AccNo: 0001015820-19-000033 Size: 170 KB 网页链接查看全文

快而精重大不利消息

美股律师郝俊波2019-10-10 09:31

2019年10月7日快而精医药Qiagen N.V. (NYSE: QGEN)宣布公司第三季度初步销售额将会远低于预期,同时还称已经担任了27年的公司首席执行官Peer M. Schatz将立即辞去首席执行官和董事会主席职位,由公司分子诊断业务高级副总裁兼负责人蒂埃里·伯纳德(Thierry Bernard)临时接任首席执行官。 受此不...查看全文

chuminhua2019-10-09 11:29

$Illumina(ILMN)$ $快而精医药(QGEN)$ 10/7,Illumina和Qiagen达成为期15年的协议,共同开发和销售可与Illumina的NextSeq 550Dx和MiSeq Dx系统配套使用的基于下一代测序的体外诊断试剂盒。 根据该协议,Qiagen将拥有开发和商业化可与这些系统配套使用的IVD产品并将其商业化的非排他权益,以及将交...查看全文

快而精医药(QGEN)2019-06-08 05:15

$快而精医药(QGEN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-06-07 AccNo: 0000215457-19-008070 Size: 13 KB 网页链接查看全文

快而精医药(QGEN)2019-05-08 19:15

$快而精医药(QGEN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-08 AccNo: 0001015820-19-000016 Size: 430 KB 网页链接查看全文

快而精医药(QGEN)2019-05-08 19:15

$快而精医药(QGEN)$ SD - Filed: 2019-05-08 AccNo: 0001015820-19-000014 Size: 20 KB 网页链接查看全文

快而精医药(QGEN)2019-05-08 19:15

$快而精医药(QGEN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-08 AccNo: 0001015820-19-000018 Size: 1 MB 网页链接查看全文

快而精医药(QGEN)2019-04-27 07:35

$快而精医药(QGEN)$ 美东时间 2019-05-06 盘后 披露财报,预期EPS 0.26 网页链接查看全文

快而精医药(QGEN)2019-03-06 19:15

$快而精医药(QGEN)$ IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Filed: 2019-03-06 AccNo: 0001015820-19-000010 Size: 31 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

专项披露公告

快而精医药(QGEN)06-01 18:06

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接查看全文

财报披露

快而精医药(QGEN)04-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)04-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接查看全文

定期披露文件

快而精医药(QGEN)03-14 19:36

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接查看全文

年度财报

快而精医药(QGEN)03-14 19:27

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30